NCT02339571 2026-03-19
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
National Cancer Institute (NCI)
Phase 2/3 Active not recruiting
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Children's Oncology Group
St. Jude Children's Research Hospital
Children's Oncology Group
National Cancer Institute (NCI)
University of Washington
National Cancer Institute (NCI)
Sellas Life Sciences Group
University of Washington
Roswell Park Cancer Institute